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Membrane Chromatography Cassettes for Bind & Elute Applications 
of Viruses and Large Proteins
Fischer-Fruehholz, S., Leuthold, M., Weisshaar, S., Taft, F., Hirai, M.
Sartorius Stedim Biotech GmbH, August-Spindler-Str. 11, D-37079 Goettingen, Germany.
Vaccine Technology VII, Engineering Conferences International, Fairmont Tremblant, Mont Tremblant, Quebec, Canada, June 17 – 22, 2018
1. Introduction
For flow-through polishing applications membrane adsorbers have become a well-established 
technology. However, there is an increasing demand for bind and elute purifications for  
larger targets as adeno- and lentiviruses, virus like particles (VLP) and influenza.1 The reason 
is the higher binding capacity of macroporous membranes compared to conventional resins 
having much smaller pores and excluding them by size.
Figure 2a: Sartobind® Jumbo 5 L as largest 
adsorber size
2. The cassette design: 2 membrane stacks 4 | 8 mm
3. Comparison of capsule and cassette fluid paths
Figure 5 shows the construction of the standard membrane adsorber devices in the 4 and 8 mm 
void volume optimized design. In the cassette (Fig. 6) the same flow principle is applied as in the 
existing capsules as feed flows perpendicular through the membrane and through void volume 
optimized fluid channels.
Figure 5: Design and flow path of void volume optimized 
adsorber capsules in 8 mm (left) and 4 mm (right) bed height.
4. Scaleability
The scale-up from existing adsorber capsules to cassettes is essential. 
6. Summary
The Sartobind® Cassette system is a prerequisite for large scale bind & elute membrane 
chromatography. Combined with anion exchangers and newly developed virus capture 
membranes such as sulfated cellulose adsorbers it intensifies manufacturing of virus and 
VLP.
7. References
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Figure 1: Typical modes of operations and applications for membrane adsorbers in the biopharmaceutical industry. 
Ligands: S = sulfonic acid for cation exchange (CIEX), Phenyl as hydrobhobic interaction chromatography ligand (HIC),  
Q = quaternary ammonium, STIC = STIC PA primary amine (salt tolerant) for anion exchange (AIEX), SC = sulfated cellulose (*) 
prototype, heparine pseudo affinity (HEP)
But capture applications with such devices suffered from the current size limitation of  
5 liters e.g. in the Sartobind® Q or S Jumbo 5 L. (Fig. 2a) Here we describe a modular  
cassette system which has been tested for scale-up and flow performance in comparison 
with void volume optimized capsules. The goals were to create a system up to 20 L  
membrane volume which can be optionally expanded to ~100 liter and, be able adapt  
exactly to the size needed (modular), using the same 4 and 8 mm bed height as the  
capsules and membranes for single- or intra batch re-use.
In capsules the membrane is rolled up. To achieve the same flow pattern in the cassette, a 
cut through a capsule suggests two stacks of membrane with a central inlet flow channel. 
The fluid enters on top between the stacks and travels through these to the outside (down-
stream) channels and then to the outlet (Fig. 2b). By this design approach the principal 
fluid path is maintained.
Figure 2b: Design for the cassette is derived from the capsule by cutting 
and creating two membrane stacks.
Figure 3 shows the realized cassette with a size of 634 + 387 + 47 mm and a dry weight  
of 4.9 kg (6.0 kg wet). The cassette can be assembled in a pilot filter holder which  
accommodates up to 13 cassettes (20.8 L, Fig. 4c) and are run with one manifold feed-
ing the liquid in the upstream distribution channels and one manifold of the downstream 
channel (Fig. 4a). A process holder has been designed for up to ~100 L membrane (Fig 4b).
Figure 3: Design of Sartobind® Cassette Figure 4a: Symmetrical manifolds at both ends of cassette pack 
are needed to connect the setup to a chromatography skid
Bed height Nano mL 5” mL 10” mL 20” mL 30” mL Jumbo mL Cassette mL
4 mm 1 75 200 400 600 2500 800
8 mm 3 150 400 800 1200 5000 1600
Table 1: Existing Sartobind® membrane chromatography capsule portfolio with 4 mm and 8 mm bed height and Cassette  
membrane volumes
L
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Figure 6: Design and flow path of void volume optimized 
adsorber cassettes in 8 mm (left) and 4 mm (right) bed height.
L
L
L
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Central spacer channels
Fleece 
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Figure 7: BSA breakthrough curves of void volume optimized capsules and single, 3 + 1.6 L cassette and 
10 × 1.6 L cassette, 8 mm bed height versions.
To compare breakthrough performance, devices were loaded with a 2 g/L bovine serum  
albumin (BSA) solution in 20 mM Tris/HCl pH 7.2. The equilibration was performed using  
5 MV of equilibration buffer. The flow rate was 5 MV/min. 1.6 L Q Cassette setups displayed 
the same shape of breakthrough as the optimized capsule product line (Fig. 7). 
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Figure 4b: 100 L Process Holder
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Load [MV]
nano 3 mL
5 inch 150 mL 
10 inch 400 mL
20 inch 800 mL
30 inch 1.2 L 
Jumbo 5 L
Cassette 1.6 L
10 × Cassette 1.6 L = 16 L
3 × Cassette 1.6 L = 4.8 L
5. Virus capture on AIEX (Q) and sulfated cellulose (SC) 
adsorbers vs. resins
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Anion exchanger Q – Adenovirus Type 5 virus particles/mL
Sartobind Q Resin Q
Column volumes: 1.0 mL (Sartobind Q), 20 mL (Resin Q) 
Flow rate: 15 CV/min (Sartobind Q), 0.15 CV/min (Resin Q) 
Feed: 8.3 × 1012 VP/mL in 50 mM HEPES, 200 mM NaCI, pH 7.5
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Sartobind SC Resin SC BResin SC A
Sulfated Cellulose – Influenza A/Puerto Rico/8/1934 (H1N1) virus particles/mL
Column volumes: 0.08 mL (SC), 0.18 mL (Resin A, Resin B) 
Flow rate: 3.75 CV/min (SC), 0.67 CV/min (Resin A), 1 CV/min (Resin B) 
Feed: 6 × 1007 VP/mL, 30 kHAU/mL in 10 mM TRIS, pH 7.4
Figure 4c: 13 Cassettes (20.8 L) in the Pilot Filter Holder
Development idea for a modular system with low complexity and smallest 
footprint 
page 1 
Membrane is rolled to cylinders in the capsules. When roll is cut and unrolled, two 
membrane stacks are formed and flow pattern of capsules can be maintained in a 
flat cassette format. 
Comparison of Sartobind Q binding capacity 
for Ad 5 displays about 9 times more bind-
ing capacity and ~100 times higher flow rate 
compared to a conventional resin.2
Evaluation of the recently developed SC dis-
plays ~5 to 7 × higher binding capacity of vi-
rus particles (VP)/mL, HAU/mL and ~6 × high-
er flow rate than conventional resin columns.3
Large Scale Modular Membrane Chromatography Cassettes
Fischer-Fruehholz, S., Leuthold, M., Weisshaar, S., Hirai, M.
Sartorius Stedim Biotech GmbH, August-Spindler-Str. 11, D-37079 Goettingen, Germany.
Upstream & Downstream Technology Forum, Rockville, MD, US, October 26, 2016
1. Intr duction
For flow-through polishing applications membrane adsorbers have become a
well-established technology. However, there is an increasing demand for bind
and elute purifications for larger targets as adeno- and lentiviruses, virus like
particles (VLP) and influenza.1 The reason is the higher binding capacity of
macr porous membran s compared to conventional resins having much smaller
por s and exclu i g them by s ze.
Figure 2a: Sartobind® Jumbo 5 L
2. The cassette design: 2 membrane stacks 4 | 8 mm
3. Comparison of capsule and cassette fluid paths
Figure 7 shows the construction of the standard membrane adsorber devices
in the 4 and 8 mm void volume optimized design. In the developed cassette
(Figure 8) the same flow principle is applied as in the existing capsules as
feed travels perpendicular through the membrane layers through void
lume optim zed fluid fluid chann ls.
7
leability
 scale-up f from existing adsorber capsules o cassettes is essential.  
The pressure-flow dependency as well as the break through behaviour was
analyzed comparing Sartobind® Q 1.2 L size with 10 + 1.6 L cassettes in terms
of pressure and flow (see figure 9). Flow performance of capsules and  
cassettes are on the same level.
6. Summary
The design limitation of capsules to 5 L membrane volume has been overruled  
by a cassette system which allows the setup of modular membranes in discrete 
volumes up to the 20 L range. The results confirm the scalability of void volume 
optimized membrane chromatography devices with cassettes following the same 
design principles and adsorber flow performance without compromising on back 
pressure.
The Sartobind® Cassette system is a prerequisite for large scale bind & elute
me brane chromatography. Combined with newly developed virus capture
membranes such as sulfated cellulose adsorbers it may supply a step towards
high speed manufacturing of virus and VLP vaccines to ending the shortage
of vaccine supply.
7. References
(1) Opitz L.: Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus
particles. Biotechnol Bioeng 2009 103(6), 1144-1154.
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Figure 1: Typical modes of operations and applications for membrane adsorbers in the biopharmaceutical industry. 
Ligands: S = sulfonic acid for cation exchange (CIEX), Phenyl, Q = quaternary ammonium, STIC = STIC PA primary amine  
(salt tolerant) for anion exchange (AIEX)
But capture applications with such devices suffered from the current size
limitation of 5 liters e.g. in the Sartobind® Q or S Jumbo 5 L.
Here we describe the develo ent of a modular cass tte system which has
been tested for scale-up and flow performance in comparison with void volume
optimized capsules. The goals are to create a system up to 20 L membrane
volume, be able adapt exactly to the size needed (modular), using the same  
4 and 8 mm bed height as the commercially available cassettes for single- or
intra batch re-use and incorporating the membrane portfolio as listed above.
In capsules the membrane is rolled up. To achieve the same flow pattern in  
the cassette, a cut through a capsule suggests two stacks of membrane with  
a central inlet flow channel. The fluid enters on top between the stacks and
travels through the two these to the outside (downstream) channels and then
to the outlet. By this design approach the principal fluid path is maintained.
Figure 2b: Design for the cassette is derived from the capsule 
by cutting and creating thus two membrane stacks.
Figure 3 shows the realized cassette with a size of 634 + 387 + 49 mm and  
a dry weight of 4.5 kg. The cassette can be assembled in a holder which
accommodates up to 13 cassettes (20.8 L) which are run with one manifold
feeding the liquid in the upstream distribution channels and one manifold  
of the downstream channel.
Figure 3: Design of Sartobind® cassette
Figure 4: Symmetrical manifolds at both ends of cassette 
pack (picture right showing 10 + 1.6 L cassettes) are needed  
to connect the setup to a chromatography skid
Bed height Nano mL 5” mL 10” mL 20” mL 30” mL Jumbo mL Cassette mL
4 mm 1 75 200 400 600 2500 800
8 mm 3 150 400 800 1200 5000 1600
Table 1: Existing Sartobind® membrane chromatography capsule portfolio with 4 mm and 8 mm bed height and Cassette  
membrane volumes
8
Fi re 9: Pressure flow comparison of an opti ized capsule 
(1.2 L) to a setup of 10 + 1.6 L cassette prototypes
Figure 10: BSA breakthrough curves of void volume  
optimized (1.2 L) and non-optimized capsules with two single 
and a 3 + 1.6 L cassette prototype setup.
To compare breakthrough performance, devices were loaded with a 2 g/L bovine 
serum albumin (BSA) solution in 20 mM Tris/HCl pH 7.4. The equilibration was 
performed using 5 MV of equilibration buffer. The flow rate was 5 MV/min. 1.6 L 
Cassette prototype A and B as well as 3 + 1.6 L displayed the same shape of  
breakthrough as the optimized capsule (1.2 L). The non (void volume) optimized 
capsule (Sartobind Q SingleSep® 540 mL) displayed no scaleability. The overlay  
of the breakthrough shows the scalability of the void volume optimized design 
concept which includes also the cassettes.
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